PhreesiaPHR +10.30%65 Market Cap is $622.4 Mil as of Jun. 26, 2026. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Phreesia ranks better than 73.74% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Phreesia's share price for the quarter that ended in Apr. 2026 was $9.21. Phreesia's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 61.8 Mil. Therefore, Phreesia's market cap for the quarter that ended in Apr. 2026 was $568.9 Mil.
Phreesia's quarterly market cap
declined
from Oct. 2025 ($1,363.7 Mil) to Jan. 2026 ($814.7 Mil) and
declined
from Jan. 2026 ($814.7 Mil) to Apr. 2026 ($568.9 Mil).
Phreesia's annual market cap
increased
from Jan. 2024 ($1,435.9 Mil) to Jan. 2025 ($1,671.4 Mil) but then
declined
from Jan. 2025 ($1,671.4 Mil) to Jan. 2026 ($814.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Phreesia's Enterprise Value for Today is $640.3 Mil.
Phreesia (NYSE:PHR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Phreesia Market Cap Related Terms
Phreesia Market Cap Historical Data
* Premium members only.
The historical data trend for Phreesia's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Phreesia's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Market Cap distribution charts can be found below:
* The bar in red indicates where Phreesia's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Phreesia's Market Cap for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia (PHR) has a Market Cap of $622.4 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #183 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 26.3%.
Is Phreesia's Market Cap too high?
Phreesia's current Market Cap is $622.4 Mil. The Healthcare Providers & Services industry median Market Cap is 93.63. Phreesia's value of $622.4 Mil is 564.7% above this industry median. Based on the distribution chart, Phreesia ranks #183 out of 697 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Market Cap compare to HSTM and WEAV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #183 out of 697 companies for Market Cap. This puts Phreesia in the upper half of its industry. The industry median Market Cap is 93.63. Phreesia's value of $622.4 Mil is 564.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current Market Cap of $622.4 Mil is 564.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current Market Cap is $622.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $10.07 — trading 62.7% below its estimated fair value. The current Market Cap is $622.4 Mil and 564.7% above the Healthcare Providers & Services industry median of 93.63. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Phreesia (PHR), the current Market Cap is $622.4 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (PHR) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of $10.07 is trading 62.7% below its estimated GF Value™ of $26.97.
GuruFocus considers Phreesia to be Possible Value Trap.
Key valuation signals for PHR:
Market Cap: $622.4 Mil
GF Value™: $26.97 vs. price of $10.07 (62.7% below fair value)
Industry Position: 564.7% above the Healthcare Providers & Services median (#183 of 697)
No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for PHR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHR has been successfully added to your 
